Avance Clinical CEO Yvonne Lungershausen Named Finalist for CEO of the Year Award in Healthcare

Pioneering Leadership in Clinical Trials

Yvonne Lungershausen’s journey in clinical research began at Adelaide University and CSIRO, where her early work in academic bench research laid the foundation for a career dedicated to improving clinical trial processes. As a founding member of CPR Pharma Services, which evolved into Avance Clinical in 2019, Yvonne has been at the forefront of transforming early-phase clinical trials in Australia. Her leadership has not only driven the company's growth but has also positioned Avance Clinical as a trusted partner for biotech  companies worldwide.

With over three decades of experience, Yvonne is highly respected for her deep industry insight, strategic vision, and commitment to fostering innovation. Under her leadership, Avance Clinical has expanded its global footprint, with operations now spanning Australia, the United States, and Asia. Her efforts have been instrumental in highlighting the unique advantages of conducting early-phase trials in Australia, such as the 43.5% R&D tax rebate, faster timelines, and world-class data accepted by the FDA and EMA.

Client-Centric Strategies and Global Expansion

Yvonne’s leadership philosophy centers on a client-centric approach, where understanding and addressing the unique needs of each client is paramount. This commitment to personalized service has resulted in high client satisfaction and loyalty, solidifying Avance Clinical’s reputation in the clinical research industry.

Her strategic focus on global expansion has also seen Avance Clinical establish a significant presence in key international markets, including the United States and Asia. The recent expansion into Seoul, Korea, and strategic partnerships across these regions are testaments to Yvonne’s vision of providing comprehensive, globally accessible clinical trial solutions for biotechs.

Recognizing Excellence in Leadership

Yvonne Lungershausen’s nomination for CEO of the Year in the Healthcare category is a fitting recognition of her outstanding contributions to the clinical trials sector and beyond. The awards ceremony, set to take place later this year in Sydney, will celebrate Australia’s top executives who are making significant impacts in their fields.

We congratulate Yvonne on this well-deserved recognition and look forward to celebrating her continued success and leadership. For more information on the awards and the full list of finalists, visit The CEO Magazine’s official announcement here.